Biogen (BIIB) P/E ratio

P/E ratio today
108.8×

Biogen (BIIB) trades at 108.8× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 20.0×. That is 46.4% higher than the 13.7× of fiscal 2024. Figures as of 19 Nov 2026, 11:14 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio today
108.8×
P/E ratio, fiscal 2025
20.0×
Change on fiscal 2024
+46.4%
Highest on record
35.8×fiscal 2013
Lowest on record
9.4×fiscal 2019
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Biogen P/E ratio, in more detail

Today's figure is 443.6% above the fiscal 2025 year-end.

Across the 19 fiscal year-ends on record (2007–2025), the highest was 35.8× in fiscal 2013 and the lowest 9.4× in fiscal 2019. Today's P/E ratio is above every one of the 19 fiscal year-ends on record; their median is 20.0×.

History · 19 fiscal years

P/E ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Biogen P/E ratio, year by year

Biogen (BIIB) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
Today108.8×—$251.41—
202520.0× 46.4% up$175.99$8.79
202413.7× 57.9% down$152.92$11.18
202332.5× 144.7% up$258.77$7.97
202213.3× 42.5% down$276.92$20.87
202123.1× 133.7% up$239.92$10.40
20209.9× 4.5% up$244.86$24.80
20199.4× 32.3% down$296.73$31.42
201813.9× 47.8% down$300.92$21.58
201726.7× 59.6% up$318.57$11.92
201616.8× 16.1% down$283.58$16.93
201520.0× 27.2% down$306.35$15.34
201427.4× 23.3% down$339.45$12.37
201335.8× 40.9% up$279.57$7.81
201225.4× 16.4% up$146.37$5.76
201121.8× 28.3% up$110.05$5.04
201017.0× 6.6% up$67.05$3.94
200916.0× 11.1% down$53.50$3.35
200818.0× 37.2% down$47.63$2.65
200728.6×—$56.92$1.99

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

P/E ratio at health care companies of similar size

P/E ratio of Biogen and comparable companies
CompanyP/E ratio
Royalty Pharma RPRX44.9×
Biogen BIIB108.8×
GE HealthCare Technologies GEHC17.7×
Alcon ALC54.9×
Mettler-Toledo International MTD37.7×
Centene CNC23.2×

Price over the last twelve months' earnings per share, as the market data feed reports it.

More on BIIB

Biogen, figure by figure

Biogen (BIIB) overview: price, valuation and scorecardAll health care companies by market value

Biogen P/E ratio: questions and answers

What is Biogen's P/E ratio?

Biogen (BIIB) trades at 108.8× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 20.0×. That is 46.4% higher than the 13.7× of fiscal 2024.

Is Biogen's P/E ratio high or low compared with its own history?

Today's P/E ratio is above every one of the 19 fiscal year-ends on record; their median is 20.0×.

What are the highest and lowest P/E ratio figures on record for Biogen?

Across the 19 fiscal year-ends on record (2007–2025), the highest was 35.8× in fiscal 2013 and the lowest 9.4× in fiscal 2019.

How is Biogen's P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E. For Biogen it is on record here for 19 fiscal years, 2007 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Biogen (BIIB) P/E ratio”, data as of 19 November 2026. https://funkfolio.com/stock/BIIB/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.